Skip to main content

Want a detailed portfolio tracker?

Mural Oncology (MURA) P/E (2023 - 2026)

Mural Oncology (MURA) P/E from Nov 16, 2023 to Jun 3, 2026. The TTM Mural Oncology (MURA) P/E is -0.29. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Mural Oncology (MURA)

YearP/EChange
2026-0.29N/A
2025-0.29-30.74%
2024-0.43-14.41%
2023-0.50N/A

Comparison Mural Oncology (MURA) P/E with competitors

Mural Oncology (MURA) P/E is -0.29.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.58%
NBYStablecoin Development Corp0.10-134.65%
ENLVEnlivex Therapeutics Ltd0.15-150.92%
FGENFibroGen Inc0.24-181.37%
TRAWTraws Pharma Inc0.47-260.28%
FBIOFortress Biotech Inc0.71-339.34%
CHRSCoherus Biosciences Inc0.98-431.58%
ORMPOramed Pharmaceuticals Inc1.47-599.50%
AGENAgenus Inc2.05-794.43%
VIVSVivoSim Labs Inc2.54-959.63%
INVAInnoviva Inc3.19-1180.90%
CRMDCorMedix Inc3.65-1335.89%
ABEOAbeona Therapeutics Inc4.20-1525.50%
VXRTVaxart Inc4.26-1544.69%
CVACCureVac N.V.4.45-1607.07%
SRPTSarepta Therapeutics Inc4.62-1667.61%
GLPGGalapagos NV4.86-1747.14%
RIGLRigel Pharmaceuticals4.92-1767.72%
ZVRAZevra Therapeutics Inc4.97-1786.20%
ABUSArbutus Biopharma Corp5.69-2030.18%
CGENCompugen Ltd7.38-2603.18%
AUPHAurinia Pharmaceuticals Inc9.25-3236.28%
ACADAcadia Pharmaceuticals Inc9.59-3350.39%
OMEROmeros Corporation9.88-3450.53%
PLXProtalix BioTherapeutics Inc9.91-3459.24%
SPROSpero Therapeutics Inc10.73-3739.13%
ADMAAdma Biologics Inc11.33-3941.14%
SVASinovac Biotech Ltd11.44-3976.88%
TBPHTheravance Biopharma Inc11.78-4092.34%
HRMYHarmony Biosciences Holdings Inc12.18-4229.23%
TGTXTG Therapeutics Inc13.18-4567.91%
INCYIncyte Corp13.38-4636.59%
SABSSAB Biotherapeutics Inc14.06-4865.66%
XOMAXOMA Corp14.95-5166.53%
REGNRegeneron Pharmaceuticals Inc14.98-5178.39%
PBYIPuma Biotechnology Inc15.05-5202.19%
EXELExelixis Inc15.79-5454.55%
NAGENiagen Bioscience Inc16.35-5644.43%
CPRXCatalyst Pharmaceuticals Inc17.34-5979.98%
MDXGMimedx Group Inc17.38-5990.35%
ARGXArgen X SE23.07-7921.42%
HALOHalozyme Therapeutics Inc23.20-7965.15%
XOMAOXOMA Corp25.34-8692.05%
VRTXVertex Pharmaceuticals Inc25.66-8797.49%
XOMAPXOMA Corp25.67-8802.33%
CTMXCytomX Therapeutics Inc25.70-8811.76%
ASNDAscendis Pharma A/S26.35-9034.22%
RPRXRoyalty Pharma plc - Class A27.50-9421.13%
SLNOSoleno Therapeutics Inc29.02-9936.39%
LGNDLigand Pharmaceuticals Inc - Class B30.19-10333.44%
BMRNBiomarin Pharmaceutical Inc37.51-12815.22%
APLSApellis Pharmaceuticals Inc39.02-13328.45%
KRYSKrystal Biotech Inc39.70-13557.75%
GMABGenmab40.20-13729.29%
ONCBeiGene Ltd67.03-22822.61%
TECHBio-Techne Corp68.59-23354.21%
VCELVericel Corp80.63-27433.88%
PHARPharming Group N.V.87.74-29844.54%
ALNYAlnylam Pharmaceuticals Inc124.93-42453.41%
TLXTelix Pharmaceuticals Ltd139.89-47523.94%
CORTCorcept Therapeutics Inc158.39-53795.11%